Scinovex
article Open AccessTop 10% cited

Flavonoids as DNA Topoisomerase Antagonists and Poisons: Structure-Activity Relationships

Journal of Natural Products · 1995 · Vol. 58(2) · pp. 217–225
Andreas I. ConstantinouRajendra MehtaConstance E. RunyanK. V. N. RaoA. VaughanRichard Moon

Abstract

Selected flavonoids were tested for their ability to inhibit the catalytic activity of DNA topoisomerase (topo) I and II. Myricetin, quercetin, fisetin, and morin were found to inhibit both enzymes, while phloretin, kaempferol, and 4',6,7-trihydroxyisoflavone inhibited topo II without inhibiting topo I. Flavonoids demonstrating potent topo I and II inhibition required hydroxyl group substitution at the C-3, C-7, C-3', and C-4' positions and also required a keto group at C-4. Additional B-ring hydroxylation enhanced flavonoid topo I inhibitory action. A C-2, C-3 double bond was also required, but when the A ring is opened, the requirement for the double bond was eliminated. Genistein has been previously reported to stabilize the covalent topo II-DNA cleavage complex and thus function as a topo II poison. All flavonoids were tested for their ability to stabilize the cleavage complex between topo I or topo II and DNA. None of the agents stabilized the topo I-DNA cleavage complex, but prunetin, quercetin, kaempferol, and apigenin stabilized the topo II DNA-complex. Competition experiments have shown that genistein-induced topo II-mediated DNA cleavage can be inhibited by myricetin, suggesting that both types of inhibitors (antagonists and poisons) interact with the same functional domain of their target enzyme. These results are of use for the selection of flavonoids that can inhibit specific topoisomerases at specific stages of the topoisomerization reaction.

Cancer therapeutics and mechanismsSynthesis and biological activityBioactive Compounds and Antitumor AgentsCitationTopoisomeraseSocial mediaInformation retrievalComputer scienceAltmetricsWorld Wide WebLibrary scienceDNABiology

MeSH terms

DNA DamageDNA Topoisomerases, Type IIDNA Topoisomerases, Type IElectrophoresis, Agar GelFlavonoidsHydroxylationPlasmidsProtein ConformationStructure-Activity RelationshipTopoisomerase I InhibitorsTopoisomerase II Inhibitors

Funding

  • Bristol-Myers Squibb
  • U.S. Public Health Service
Citations
274
FWCI
2.70
field-weighted impact
References
0
Percentile
91%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Flavonoids as DNA Topoisomerase Antagonists and Poisons: Structure-Activity Relationships · Scinovex